SELFI研究:油溶性对比剂子宫输卵管造影术后的碘过量与甲状腺功能障碍
这项前瞻性队列研究纳入196例无显性甲减或甲亢的连续同意女性,2019-2021年在奥克兰接受油溶性对比剂子宫输卵管造影术,并连续监测24周促甲状腺激素、游离甲状腺素和尿碘浓度。结果显示碘过量几乎普遍存在(98%),亚临床甲减发生率为38%,多数为轻度且多在4周内出现,甲亢发生率为5%;作者认为术后6个月内需定期检测甲状腺功能。
要点
- 油溶性对比剂子宫输卵管造影术后碘过量几乎普遍(98%),尿碘浓度多在4周达峰。
- 亚临床甲减发生率为38%,其中96%为轻度(促甲状腺激素4-10 mIU/L),75%在4周内出现。
- 甲亢(促甲状腺激素<0.3 mIU/L)发生于9例(5%);作者认为术后6个月需定期检测甲状腺功能。
核心结论
- 油溶性对比剂子宫输卵管造影术导致显著且持久的碘过量,亚临床甲减常见,偶见迟发性甲亢;作者认为术后6个月内需定期检测甲状腺功能。
研究设计与样本
- 前瞻性队列研究,纳入196例无显性甲减或甲亢的连续同意且符合条件的女性,均完成研究且依从性大于95%。
- 参与者于2019-2021年在奥克兰接受油溶性对比剂子宫输卵管造影术,并连续监测促甲状腺激素、游离甲状腺素和尿碘浓度24周。
主要发现
- 碘过量(尿碘浓度≥300 μg/L)几乎普遍存在(98%),尿碘浓度通常在第4周达峰。
- 90%的参与者尿碘浓度≥1000 μg/L,17%的参与者尿碘浓度>10000 μg/L。
- 67%的参与者尿碘浓度≥1000 μg/L持续至少3个月。
- 亚临床甲减发生于38%的参与者,其中96%为轻度(促甲状腺激素4-10 mIU/L),75%在4周内出现亚临床甲减;3例符合当前治疗指南(促甲状腺激素>10 mIU/L)。
- 甲亢(促甲状腺激素<0.3 mIU/L)发生于9例参与者(5%)。
关键数值与推荐
- 亚临床甲减定义为非妊娠状态下促甲状腺激素>4 mIU/L且游离甲状腺素正常(11-22 pmol/L),见于基线甲状腺功能正常者。
- 碘过量定义为尿碘浓度≥300 μg/L。
- 3例参与者符合当前治疗指南(促甲状腺激素>10 mIU/L)。
- 轻度亚临床甲减的甲状腺素治疗倾向于改善妊娠成功(P = .063)。
临床怎么用
- 作者认为油溶性对比剂子宫输卵管造影术后6个月内需定期检测甲状腺功能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Hysterosalpingography (HSG) with oil-soluble contrast medium (OSCM) improves pregnancy rates. However, OSCM has high iodine content and long half-life, leading to potential iodine excess. OBJECTIVE: This work aimed to determine the pattern of iodine excess after OSCM HSG and the effect on thyroid function. METHODS: A prospective cohort study was conducted of 196 consecutive consenting eligible women without overt hypothyroidism or hyperthyroidism. All completed the study with compliance greater than 95%. Participants underwent OSCM HSG (Auckland, 2019-2021) with serial monitoring of thyrotropin (TSH), free thyroxine (FT4), and urine iodine concentration (UIC) for 24 weeks. The main outcome measure was the development of subclinical hypothyroidism (SCH), defined as a nonpregnant TSH greater than 4 mIU/L with normal FT4 (11-22 pmol/L) in those with normal baseline thyroid function. RESULTS: Iodine excess (UIC ≥ 300 μg/L) was almost universal (98%) with UIC peaking usually by 4 weeks. There was marked iodine excess, with 90% and 17% of participants having UIC greater than or equal to 1000 μg/L and greater than 10 000 μg/L, respectively. Iodine excess was prolonged with 67% having a UIC greater than or equal to 1000 μg/L for at least 3 months. SCH developed in 38%; the majority (96%) were mild (TSH 4-10 mIU/L) and most developed SCH by week 4 (75%). Three participants met the current treatment guidelines (TSH > 10 mIU/L). Thyroxine treatment of mild SCH tended to improve pregnancy success (P = .063). Hyperthyroidism (TSH < 0.3 mIU/L) occurred in 9 participants (5%). CONCLUSION: OSCM HSG resulted in marked and prolonged iodine excess. SCH occurred frequently with late-onset hyperthyroidism occasionally. Regular thyroid function tests are required for 6 months following this procedure.
引用
- Mathews DM, Peart JM, Sim RG, et al. The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography. J Clin Endocrinol Metab. 2022. PMID: 36124847. doi:10.1210/clinem/dgac546
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。